62nd Annual Meeting

October 26 - 31, 2015

Clinical Consultation Breakfast 2 (sold out)

Master Clinician: Benjamin I. Goldstein, MD, PhD: Special Topics in the Treatment of Adolescent Bipolar Disorder

Benjamin I. Goldstein, MD, PhD is an Associate Professor of Psychiatry, Pharmacology, and Psychological Clinical Science at the University of Toronto. He is a child and adolescent psychiatrist at Sunnybrook Health Sciences Centre, where he is Director of the Centre for Youth Bipolar Disorder. Dr. Goldstein’s efforts focus on teenagers with or at familial risk for bipolar disorder. His team is working to identify clinically relevant biomarkers and to identify innovative prevention and treatment strategies that integrate physical and mental health. He has authored over 100 scientific articles, and has received international awards for his research. Dr. Goldstein’s work is supported by peer-reviewed grants from the Canadian Institutes of Health Research (CIHR), the National Institute of Mental Health (NIMH), and foundations in Canada and the United States. He is an active educator and serves as Director of the Clinician Scientist Program in the University of Toronto’s Department of Psychiatry.

Numerous potential psychiatric treatment targets exist for adolescents with bipolar disorder, often concurrently, including hypo/mania, depression, anxiety, substance use, suicidality, and other risk-related behaviors. In addition, adolescents with bipolar disorder may present with suboptimal lifestyle, including nutrition and physical activity. Whereas there are several positive studies for the treatment of acute mania associated with bipolar I disorder, the evidence that clinicians can draw upon to guide their treatment of bipolar depression, maintenance treatment, comorbid anxiety, and bipolar subtypes other than type I, and adolescents at familial risk for bipolar disorder is scant. This session will focus on these and other special topics in the treatment of adolescent bipolar disorder.